127 related articles for article (PubMed ID: 10577093)
1. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
Harewood G
N Engl J Med; 1999 Oct; 341(18):1398; author reply 1398-9. PubMed ID: 10577093
[No Abstract] [Full Text] [Related]
2. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
3. Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?
Scheiman J
Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():7-8, 21-4. PubMed ID: 15755267
[No Abstract] [Full Text] [Related]
4. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
Fries JF
N Engl J Med; 1999 Oct; 341(18):1397-8; author reply 1398-9. PubMed ID: 10577092
[No Abstract] [Full Text] [Related]
5. Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs.
Jacobsen RB; Phillips BB
Ann Pharmacother; 2004 Sep; 38(9):1469-81. PubMed ID: 15213313
[TBL] [Abstract][Full Text] [Related]
6. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
7. Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005.
Hunt RH
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():10-9. PubMed ID: 16303032
[TBL] [Abstract][Full Text] [Related]
8. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
Lanas A; Ferrandez A
Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention.
Scheiman JM
Rev Gastroenterol Disord; 2005; 5 Suppl 2():39-49. PubMed ID: 16369226
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of risk factors for gastrointestinal complications and use of gastroprotection among persons hospitalized for cardiovascular disease.
Targownik LE; Al-Mamfud A
Aliment Pharmacol Ther; 2006 Mar; 23(6):743-9. PubMed ID: 16556176
[TBL] [Abstract][Full Text] [Related]
11. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
Vakil N
Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
[TBL] [Abstract][Full Text] [Related]
12. [NSAID-induced gastropathies: problems and ways of their resolutions].
Tkachenko EI; Uspenskiĭ IuP; Pakhomova IG
Eksp Klin Gastroenterol; 2006; (6):41-8. PubMed ID: 17612095
[No Abstract] [Full Text] [Related]
13. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
14. Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups.
Spiegel BM; Chiou CF; Ofman JJ
Arthritis Rheum; 2005 Apr; 53(2):185-97. PubMed ID: 15818647
[TBL] [Abstract][Full Text] [Related]
15. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
Laine L
Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
[TBL] [Abstract][Full Text] [Related]
16. What price pain relief?
Hochman JS; Shah NR
Circulation; 2006 Jun; 113(25):2868-70. PubMed ID: 16785335
[No Abstract] [Full Text] [Related]
17. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.
; Wilcox CM; Allison J; Benzuly K; Borum M; Cryer B; Grosser T; Hunt R; Ladabaum U; Lanas A; Paulus H; Regueiro C; Sandler RS; Simon L
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1082-9. PubMed ID: 16877048
[No Abstract] [Full Text] [Related]
18. Physicians' approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug users.
Murthy SK; Kauldher S; Targownik LE
Aliment Pharmacol Ther; 2006 May; 23(9):1365-72. PubMed ID: 16629943
[TBL] [Abstract][Full Text] [Related]
19. [Recommendations for treatment with nonsteroidal anti-inflammatory drugs].
Bolten WW
MMW Fortschr Med; 2005 Aug; 147(31-32):24-7. PubMed ID: 16128192
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
Laine L
Rev Gastroenterol Disord; 2004; 4 Suppl 4():S33-41. PubMed ID: 15580145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]